tiprankstipranks
Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB
UK Market
POLB
Poolbeg Pharma Ltd.
RESEARCH TOOLSreports
Want to see GB:POLB full AI Analyst Report?

Poolbeg Pharma Ltd. (POLB) Stock News & Sentiment

28 Followers
Poolbeg Pharma Publishes 2025 Annual Report and Sets June AGM Date
Premium
Company Announcements
Poolbeg Pharma Publishes 2025 Annual Report and Sets June AGM Date
14h ago
Poolbeg Pharma Signals Momentum Ahead of 2026 Data
Premium
Company Announcements
Poolbeg Pharma Signals Momentum Ahead of 2026 Data
3d ago
Poolbeg Pharma advances POLB 001 and obesity pipeline on solid 2025 funding base
Premium
Company Announcements
Poolbeg Pharma advances POLB 001 and obesity pipeline on solid 2025 funding base
10d ago
Poolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market
Premium
Company Announcements
Poolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market
23d ago
Poolbeg wins first cancer CRS patent for POLB 001 in Australia
Premium
Company Announcements
Poolbeg wins first cancer CRS patent for POLB 001 in Australia
1M ago
Poolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
Premium
Company Announcements
Poolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
2M ago
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
Premium
Company Announcements
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
3M ago
More GB:POLB News >

POLB News on the Web

Poolbeg Pharma advances POLB 001 into UK trial - ICYMI
Proactive Investors
Bullish
Cavendish sees Poolbeg MHRA clearance as key de-risking event with 313% upside to target
Proactive Investors
Neutral
Poolbeg Pharma wins UK regulatory clearance for cancer immunotherapy trial
Proactive Investors
Neutral
Poolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market
TipRanks News
Neutral
Poolbeg Pharma on patent grant and plans - ICYMI
Proactive Investors
Bullish
Poolbeg Pharma shares rise 10% as Australian patent grant bolsters POLB 001 commercial appeal
Proactive Investors
Neutral
Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment
Proactive Investors
Neutral
Poolbeg wins first cancer CRS patent for POLB 001 in Australia
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
GB:POLB
Sector Average
Media Buzz
This Week4 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:POLB’s Media Buzz Sentiment?
4 articles about GB:POLB were published this week. In an average week, 2 articles are published.
    What is GB:POLB’s weekly average amount of articles?
    In an average week, 2 articles about GB:POLB are published.
      What is GB:POLB’s News Sentiment?
      100% of articles about GB:POLB were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week